Assignee
ARETEIA THERAPEUTICS INC
US·2 granted patents·8 pending applications·1 citations·filing 2020–2025
Top patents by PatentIndex Score
10 records- 0185US2025099437A1Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophilsARETEIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0282US11612589B2Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophilsARETEIA THERAPEUTICS INC·Filed 2020·Granted Mar 28, 2023·1 cites·128 claims
- 0379US12138249B2Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophilsARETEIA THERAPEUTICS INC·Filed 2023·Granted Nov 12, 2024·0 cites·14 claims
- 0476US2026021077A1Use of dexpramipexole for the treatment of moderate to severe asthmaARETEIA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0571US2024041840A1Use of dexpramipexole for the treatment of moderate to severe asthmaARETEIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0671US2024041841A1Use of dexpramipexole for the treatment of moderate to severe asthmaARETEIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0765US2025213489A1Osmotic tablets of dexpramipexole and methods of manufacturing and use thereofARETEIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0865US2025205207A1Matrix tablets of dexpramipexole and methods of manufacturing and use thereofARETEIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0965US2025205206A1Use of dexpramipexole for the treatment of inadequately controlled moderate to severe asthmaARETEIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1044US2025352520A1Use of dexpramipexole for the treatment of eosinophilic copdARETEIA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →